Skip to main content
News Icon

News categories: Honors & Funding

Honorary doctorate to Professor Jacques Miller

The University of Bonn Faculty of Medicine has awarded an honorary doctorate to renowned Australia-based immunologist Prof. Dr. Jacques Francis Albert Pierre Miller. The award ceremony was conducted online due to the corona pandemic, held as part of the Digital Cluster Science Days 2020 organized by the Cluster of Excellence ImmunoSensation2.

The ceremony took place via simultaneous videoconferencing between the lecture hall of Biomedical Center I on the Venusberg Campus and Melbourne, Australia, where Professor Miller (89) is Professor Emeritus at the Walter and Eliza Hall Institute of Medical Research. One of Miller’s former doctoral students, Professor Robyn Slattery, presented the diploma following the ceremonial pronouncement of awarding of the honorary doctorate by Professor Bernd Weber as Dean representing the University of Bonn. Speeches in honor of the recipient were made by Leibniz Prize winner Professor Christian Kurts and by Professor Sammy Bedoui, Bonn University Ambassador in Melbourne, Australia.

The board of the ImmunoSensation2 Cluster of Excellence had suggested to confer the honorary degree in recognition of Professor Miller’s outstanding achievement in the field of immunology. Jaques Miller earned wide scientific attention in the 1960s for proving that the thymus is a critically important component of the immune system as the organ where T cells are formed. The existence of T cells, as well as their key role in immunological memory against bacteria, viruses and cancer had not been appreciated prior to this discovery.

Congratulations Jaques Miller for this honorary degree and the Cluster ImmunoSensation is happy to have such close ties with its partners the University of Melbourne in operating The Bonn and Melbourne Research and Graduate School (Bo&MeRanG) for the Immunosciences.


Media contact

Prof. Dr. Christian Kurts

Phone: +49 (0) 228 287-11050

Email: ckurts@uni-bonn.de

Related news

Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry
Prof. Dr. Jörg Wenzel

News categories: Honors & Funding

Jörg Wenzel elected chair of EADV Task Force on Cutaneous Lupus Erythematosus (CLE)

The European Academy of Dermatology and Venereology (EADV) has establishment a new Task Force on Cutaneous Lupus Erythematosus (CLE), led by ImmunoSensation³ member Jörg Wenzel. CLE, as autoimmune disease of the skin, is a prime example of chronic inflammatory dysregulation, leading to a severe disease burden. The treatment of cutaneous lupus continues to face unresolved clinical challenges. The CLE Task Force is set up to push the boundaries of clinical care, update guidelines, and advance collaborative research across Europe.
EADV Task Forces
News Marvin Supercomputer

News categories: Honors & Funding

Two years of the Marvin Supercomputer: Researchers in Bonn present their projects

Two years after it went into operation, the University of Bonn celebrated the Marvin Supercomputer with a community event at the Research and Technology Center for Detector Physics (FTD). Researchers from various disciplines presented projects that had been carried out using high-performance computing and used the event as an opportunity for interdisciplinary exchange. A team lead by ImmunoSensation³ members Prof. Dr. Michael Hölzel (Institute of Experimental Oncology) and PD Dr. Gregor Hagelueken (Institute of Structural Biology) use Marvin to design new proteins.
View entry

Back to the news overview